Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships
Partnering with outside organizations, such as small biotech firms, academic institutions, CROs and individual experts, has become vital for the health of R&D in large pharmaceutical companies.
But the traditional forms of networking are no longer sufficient for finding the best collaborators. Pharma companies are now using data analytics to help them establish successful relationships.
This white paper discusses:
- Why pharmaceutical companies need to develop partnerships with external sources
- What different kinds of collaborators can offer to pharma R&D
- Using data analysis to create an external network map of possible collaborators that identifies topics of interest, experience and relationships with competitors
Read the white paper.
To access the complimentary white paper 'Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships', please fill in the form below.
Content cannot be accessed
Elsevier's R&D Solutions supporting 'Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships'
Help researchers understand the entire breadth of research surrounding a disease by helping them more effectively and efficiently search authoritative, full-text scientific, technical and health content.
Learn more about ScienceDirect
Contact a ScienceDirect expert